HIV Alert: Emerging Updates on Dual Therapy

Listen to downloadable audio from a series of live Webinars by Joseph J. Eron, Jr., MD, and Babafemi Taiwo, MBBS, in which the use of a recently approved dual-therapy regimen and data surrounding investigational 2-drug regimens are discussed and audience questions on these subjects are addressed.
Format: Audio (.mp3)
File Size: 8.35 MB
Released: January 18, 2018

Listen to downloadable audio from a series of live Webinars by Joseph J. Eron, Jr., MD, and Babafemi Taiwo, MBBS, in which the use of a recently approved dual-therapy regimen and data surrounding investigational 2-drug regimens are discussed and audience questions on these subjects are addressed. (~45 minutes)

Joseph J. Eron, Jr., MD, has disclosed that he has received consulting fees from EMD Serono, Gilead Sciences, Janssen, Merck, Trio Health, and ViiV and funds for research support (to the University of North Carolina) from Gilead Sciences, Janssen, and ViiV.

Babafemi Taiwo, MBBS, has disclosed that he has received consulting fees from Gilead Sciences, Janssen, and ViiV and funds for research support from ViiV.

Acknowledgements

Educational grant provided by:
ViiV Healthcare

Related Content

Downloadable slideset covering key HIV studies presented at IDWeek, Comorbidities Workshop, and HIV Glasgow 2018, reported by Clinical Care Options

Babafemi Taiwo, MBBS Released: December 5, 2018

Study 1878: Suppression maintained through Week 48 after switch to BIC/FTC/TAF with M184V/I presented at Glasgow 2018 reported by Clinical Care Options

Released: November 30, 2018

Phase III NAMSAL ANRS 12313: Week 48 results from Glasgow 2018 on DTG vs EFV 400 mg + 3TC/TDF in ART-naive adults, as reported by Clinical Care Options (CCO).

Released: November 30, 2018

Subgroup analyses of safety and efficacy at Week 48 in phase III GEMINI-1 and -2 presented at Glasgow 2018 as reported by Clinical Care Options (CCO).

Released: November 30, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?